Suchergebnisse - (Standardsuche:Subject:"angiotensin II "type1" receptor blockers")

PubPharm (988)

81

COVID-19 and its relationship with hypertension and cardiovascular disease

enthalten in: Hipertension y riesgo vascular | 2020

von Salazar, M. | Barochiner, J. | Espeche, W. | +1

82

Protection of Sacubitril/Valsartan against Pathological Cardiac Remodeling by Inhibiting the NLRP3 Inflammasome after Relief of Pressure Overload in Mice

enthalten in: Cardiovascular drugs and therapy | 2020

von Li, X. | Zhu, Q. | Wang, Q. | +4

83

Isotretinoin in Treatment of COVID-19 : Evaluation of the Safety and Efficacy of Isotretinoin in Treatment of COVID-19: Clinical Study

enthalten in: ClinicalTrials.gov | 2020

84

Clinical, demographical characteristics and hospitalisation of 3,010 patients with Covid-19 in Friuli Venezia Giulia Region (Northern Italy). A multivariate, population-based, statistical analysis

enthalten in: Epidemiologia e prevenzione | 2020

von Gobbato, M. | Clagnan, E. | Burba, I. | +6

85

Ageing reduces angiotensin II type 1 receptor antagonism mediated pre-conditioning effects in ischemic kidneys by inducing oxidative and inflammatory stress

enthalten in: Experimental gerontology | 2020

von Ogbadu, J. | Singh, G. | Gupta, K. | +2

86

Status on the use of anti-hypertensive drugs in the southwest areas of China

enthalten in: Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi | 2020

von Zhang, D. | Song, L. | Li, Y. | +5

87

Injured Podocytes Are Sensitized to Angiotensin II-Induced Calcium Signaling

enthalten in: Journal of the American Society of Nephrology : JASN | 2020

von Binz-Lotter, J. | Jüngst, C. | Rinschen, M. | +6

88

Angiotensin involvement in trauma processing-exploring candidate neurocognitive mechanisms of preventing post-traumatic stress symptoms

enthalten in: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology | 2020

von Shkreli, L. | Woud, M. | Ramsbottom, R. | +4

89

Pharmacokinetics and Bioequivalence of Two Formulations of Valsartan 80 mg Capsules : A Randomized, Single Dose, 4-Period Crossover Study in Healthy Chinese Volunteers Under Fasting and Fed Conditions

enthalten in: Drug design, development and therapy | 2020

von Wu, Q. | Wang, X. | Chen, Q. | +8

90

A Pharmacokinetic Drug Interaction Between Fimasartan and Linagliptin in Healthy Volunteers

enthalten in: Drug design, development and therapy | 2020

von Kang, W. | Lee, H. | Gwon, M. | +6